In: Trials, 16 (2015), Nr. 264. pp. 1-5. ISSN 1468-6694
Preview |
PDF, English
Download (497kB) | Lizenz: ![]() |
Abstract
Background: Stereotactic body radiation therapy (SBRT)using intensity-modulated radiotherapy (IMRT) can be a safe modality for treating spinal bone metastasis with enhanced targeting accuracy and an effective method for achieving good tumor control and a rigorous pain response. Methods/design: This is a single-center, prospective randomized controlled trial to evaluate pain relief after RT and consists of two treatment groups with 30 patients in each group. One group will receive single-fraction intensity-modulated RT with 1×24 Gy, and the other will receive fractionated RT with 10×3 Gy. The target parameters will be measured at baseline and at 3 and 6 months after RT. Discussion: The aim of this study is to evaluate pain relief after RT in patients with spinal bone metastases by means of two different techniques: stereotactic body radiation therapy and fractionated RT. The primary endpoint is pain relief at the 3-month time-point after RT. Secondly, quality of life, fatigue, overall and bone survival, and local control will be assessed. Trial registration ClinicalTrials.gov identifier NCT02358720 (June 2, 2015).
Document type: | Article |
---|---|
Journal or Publication Title: | Trials |
Volume: | 16 |
Number: | 264 |
Publisher: | BioMed Central |
Place of Publication: | London |
Date Deposited: | 15 Dec 2015 10:34 |
Date: | 2015 |
ISSN: | 1468-6694 |
Page Range: | pp. 1-5 |
Faculties / Institutes: | Medizinische Fakultät Heidelberg > Radiologische Universitätsklinik Medizinische Fakultät Heidelberg > Institut für Medizinische Biometrie |
DDC-classification: | 610 Medical sciences Medicine |